Smart incentives for sharing knowledge, not the indiscriminate elimination of IP rights, will get us to the finish line, says Sánchez-Oldenhage.
COVID-19 offers the potential for pharma companies to disrupt the marketing and sales business model and aim at achieving functional excellence.
“Mexico lacks an angel investor system, which complicates the creation of new companies
Not everyone likes uncertainty, but many investors see a silver lining, particularly in Mexico’s health sector.
View from the Top
Owner and CEO
PharmAdvice is a pharmaceutical, biotechnology and healthcare consulting services company.